Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND2 pseudogene 20 (MTND2P20) is a nuclear-encoded pseudogene related to the mitochondrial gene MT-ND2, which encodes a subunit of Complex I in the mitochondrial respiratory chain. Unlike the functional MT-ND2, MTND2P20 is a non-coding, non-functional genomic locus that does not produce protein, mRNA, or demonstrate biological activity. It is included in gene nomenclature records (for example, HGNC:42121) solely for sequence annotation and genomic mapping. It has no established biological function, therapeutic target role, nor pathological significance[2]. Key note: Pseudogenes such as MTND2P20 are common throughout the genome and are remnants of gene duplication or mitochondrial DNA insertion events; these sequences are not transcribed or translated into protein and are not considered therapeutic targets under current biomedical paradigms[7]. Additional context: The parent gene (MT-ND2) is a well-studied gene coding for a critical component of mitochondrial Complex I, with clear roles in electron transport and clinical disease when mutated[1][3][4]. However, MTND2P20 does not share these functions due to its pseudogene status[2].
None (No mechanism of action)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND2 pseudogene 20 (MTND2P20).